*Boehringer Ingelheim Pharma GmbH & Co. KG v Office for Harmonisation in the Internal Market

European Union – Trade marks. The General Court of the European Union annulled the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) relating to opposition proceedings between Boehringer Ingelheim Pharma GmbH & Co. KG and Nepentes Pharma sp. z o.o. (Nepentes) regarding the application by Nepentes for registration of the word sign 'Momarid' as a Community trade mark.

Category: